by | Jan 30, 2024 | Paley, Michael, Yokoyama, Wayne
— T-020486 – Systems and Methods for Detection and Quantification of Axial Spondyloarthritis
Technology Description
Researchers at Washington University in St. Louis, led by Dr. Michael Paley, have developed an assay to diagnose axial spondyloarthritis (axSpA) in HLA-B*27-positive patients.…
by | Nov 8, 2023 | Eteleeb, Abdallah, Maher, Christopher, Silva-Fisher, Jessica
— Technology Description
Researchers in Dr. Jessica Silva-Fisher’s laboratory have developed antisense oligonucleotide targeting a long non-coding RNA (lncRNA), LINC00355, as a treatment for late-stage relapse (LSR) breast cancer. LINC00355 is highly expressed in LSR breast cancer patients and…
by | Nov 8, 2023 | Bark, David
— Paper-Based Assays for Primary Hemostasis and Thrombosis
Technology Description
Researchers in Dr. David Bark’s laboratory at Washington University have developed a method that allows for the evaluation of various flow-dependent pathways of hemostasis on microfluidic paper-based analytical d…
by | Jan 11, 2022 | Imoukhuede, Princess
— Technology Description
Researchers in the Imoukhuede lab at Washington University have developed a library of mutant PDGF-B proteins to develop more effective VEGF pathway inhibitors. As PDGF-B also binds to VEGF receptors, a mutant form can be used to block VEGF binding and stop tumor angiogenesi…
by | Nov 12, 2021 | Cabanski, Christopher, Fields, Ryan, Maher, Christopher, Silva-Fisher, Jessica
— Technology Description
Researchers in Prof. Christopher Maher’s research program (in conjunction with collaborator Ryan Fields) discovered that RAMS11 (RNA Associated with Metastasis 11), a novel long non-coding RNA, (i) promotes metastatic disease, (ii) confers resistance to topoisomerase i…